{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T14:41:21Z","timestamp":1783953681559,"version":"3.55.0"},"reference-count":24,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2011,2,10]],"date-time":"2011-02-10T00:00:00Z","timestamp":1297296000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Parasite Immunology"],"published-print":{"date-parts":[[2011,3]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Seeking biomarkers reflecting disease development in cystic echinococcosis (CE), we used a proteomic approach linked to immunological characterisation for the identification of respective antigens. Two\u2010dimensional gel electrophoresis (2\u2010DE) of sheep hydatid fluid, followed by immunoblot analysis (IB) with sera from patients with distinct phases of disease, enabled us to identify by mass spectrometry heat shock protein 20 (HSP20) as a potential marker of active CE. Using IB, antibodies specific to the 34\u2003kDa band of HSP20 were detected in sera from 61\/95 (64%) patients with CE, but not in sera from healthy subjects. IB revealed anti\u2010HSP20 antibodies in a higher percentage of sera from patients with active disease than in sera from patients with inactive disease (81 vs. 24%; <jats:italic>P<\/jats:italic>\u2003=\u200310<jats:sup>\u22124<\/jats:sup>). These primary results were confirmed in a long\u2010term follow\u2010up study after pharmacological and surgical treatment. Herewith anti\u2010HSP20 antibody levels significantly decreased over the course of treatment in sera from patients with cured disease, relative to sera from patients with progressive disease (<jats:italic>P<\/jats:italic>\u2003=\u20030\u00b7017). Thus, during CE, a comprehensive strategy of proteomic identification combined with immunological validation represents a promising approach for the identification of biomarkers useful for the prognostic assessment of treatment of CE patients.<\/jats:p>","DOI":"10.1111\/j.1365-3024.2010.01264.x","type":"journal-article","created":{"date-parts":[[2010,10,18]],"date-time":"2010-10-18T11:53:21Z","timestamp":1287402801000},"page":"193-198","source":"Crossref","is-referenced-by-count":13,"title":["Favourable prognostic value of antibodies anti\u2010HSP20 in patients with cystic echinococcosis: a differential immunoproteomic approach"],"prefix":"10.1111","volume":"33","author":[{"given":"D.","family":"VACIRCA","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"PERDICCHIO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"CAMPISI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"DELUNARDO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"ORTONA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"MARGUTTI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"TEGGI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"GOTTSTEIN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"SIRACUSANO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,2,10]]},"reference":[{"key":"e_1_2_3_2_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1202.050499"},{"key":"e_1_2_3_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(07)70134-2"},{"key":"e_1_2_3_4_2","doi-asserted-by":"publisher","DOI":"10.1155\/2009\/474368"},{"key":"e_1_2_3_5_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.10.6679"},{"key":"e_1_2_3_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.actatropica.2006.02.002"},{"key":"e_1_2_3_7_2","doi-asserted-by":"publisher","DOI":"10.1080\/00034983.2000.11813546"},{"key":"e_1_2_3_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pt.2006.07.003"},{"key":"e_1_2_3_9_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2008.79.301"},{"key":"e_1_2_3_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01689-07"},{"key":"e_1_2_3_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.200300487"},{"key":"e_1_2_3_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.200900506"},{"key":"e_1_2_3_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2010.05.013"},{"key":"e_1_2_3_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.actatropica.2009.09.003"},{"key":"e_1_2_3_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/nsmb993"},{"key":"e_1_2_3_16_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3024.2003.00617.x"},{"key":"e_1_2_3_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.exppara.2009.06.014"},{"key":"e_1_2_3_18_2","doi-asserted-by":"publisher","DOI":"10.1086\/520205"},{"key":"e_1_2_3_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0b013e328330331c"},{"key":"e_1_2_3_20_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2002.01925.x"},{"key":"e_1_2_3_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.trstmh.2008.09.020"},{"key":"e_1_2_3_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00363-07"},{"key":"e_1_2_3_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2005.02939.x"},{"key":"e_1_2_3_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0001-706X(02)00223-1"},{"key":"e_1_2_3_25_2","first-page":"231","article-title":"Guidelines for treatment of cystic and alveolar echinococcosis in humans","volume":"74","author":"Informal Working Group on Echinococcosis","year":"1996","journal-title":"Bull World Health Organ"}],"container-title":["Parasite Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-3024.2010.01264.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-3024.2010.01264.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T06:10:41Z","timestamp":1698732641000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-3024.2010.01264.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,10]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["10.1111\/j.1365-3024.2010.01264.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-3024.2010.01264.x","archive":["Portico"],"relation":{},"ISSN":["0141-9838","1365-3024"],"issn-type":[{"value":"0141-9838","type":"print"},{"value":"1365-3024","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,10]]}}}